{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Primary ciliary dyskinesia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_dornase_alfa",
          "name": "Dornase alfa"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_azithromycin",
          "name": "Azithromycin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_budenoside",
          "name": "Budenoside"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_montelukast",
          "name": "Montelukast"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ivacaftor",
          "name": "Ivacaftor"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_nebulized_antibiotics",
          "name": "Nebulized antibiotics"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_erdafitinib",
          "name": "Erdafitinib"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_roflumilast",
          "name": "Roflumilast"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_ataluren",
          "name": "Ataluren"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_cystagon",
          "name": "Cystagon"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_dornase_alfa",
          "type": "Drug",
          "label": "Dornase alfa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azithromycin",
          "type": "Drug",
          "label": "Azithromycin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budenoside",
          "type": "Drug",
          "label": "Budenoside",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_montelukast",
          "type": "Drug",
          "label": "Montelukast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ivacaftor",
          "type": "Drug",
          "label": "Ivacaftor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nebulized_antibiotics",
          "type": "Drug",
          "label": "Nebulized antibiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_erdafitinib",
          "type": "Drug",
          "label": "Erdafitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_roflumilast",
          "type": "Drug",
          "label": "Roflumilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ataluren",
          "type": "Drug",
          "label": "Ataluren",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cystagon",
          "type": "Drug",
          "label": "Cystagon",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_primary_ciliary_dyskinesia",
          "type": "Disease",
          "label": "Primary ciliary dyskinesia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_dornase_alfa",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于改善粘液清除"
        },
        {
          "source": "drug_azithromycin",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "适用于反复感染治疗，改善病情"
        },
        {
          "source": "drug_budenoside",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "减轻气道炎症"
        },
        {
          "source": "drug_montelukast",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "改善气道通畅"
        },
        {
          "source": "drug_ivacaftor",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "可改善相关表型"
        },
        {
          "source": "drug_nintedanib",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能改善肺部功能"
        },
        {
          "source": "drug_nebulized_antibiotics",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接用于治疗感染"
        },
        {
          "source": "drug_prednisone",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可用于控制炎症"
        },
        {
          "source": "drug_roflumilast",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "改善气道炎症"
        },
        {
          "source": "drug_ataluren",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "潜在作用需进一步确认"
        },
        {
          "source": "drug_cystagon",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "尚待更多证据支持"
        },
        {
          "source": "drug_erdafitinib",
          "target": "disease_primary_ciliary_dyskinesia",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "需要进一步研究以确认"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物显示出对初级纤毛运动障碍的潜在支持作用",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物具备到达呼吸道组织的有效暴露（常识判断）"
    ],
    "uncertainties": [
      "没有明确的单一疗法适应性（需进一步验证治疗组合效果）"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索药物组合疗法的有效性？"
    ]
  }
}